B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KCNH2

MOLECULAR TARGET

potassium voltage-gated channel subfamily H member 2

UniProt: Q12809NCBI Gene: 3757145 compounds

KCNH2 (potassium voltage-gated channel subfamily H member 2) is targeted by 145 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KCNH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Astemizole Antihistamine drug now withdrawn from3.6437
2dofetilide3.3327
3Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent2.7715
4Aripiprazole2.6413
5Domperidone2.6413
6Quinidine2.6413
7Loratadine2.4811
8Fluoxetine2.4010
9Reserpine2.4010
10vinpocetine2.208
11Clotrimazole2.208
12Flecainide2.208
13lidoflazine2.208
14clofilium tosylate2.087
15Fluspirilene2.087
16Vincamine2.087
17Amoxapine1.956
18Fenofibrate1.956
19Lumefantrine1.956
20Phenoxybenzamine1.956
21Duloxetine Hydrochloride1.795
22Cinnarizine1.795
23Metergoline1.795
24Nitrendipine1.795
25Ondansetron1.795
26Perphenazine1.795
27Rimonabant1.795
28Celecoxib1.614
29Dibucaine1.614
30dilazep1.614
31Flunarizine Flunarizine is1.614
32Hydroxyzine1.614
33Lovastatin1.614
34Loxapine1.614
35Maprotiline1.614
36Vitamin K 31.614
37Nebivolol1.614
38Nicergoline1.614
39Nylidrin1.614
40oxatomide [Supplementary Concept] structure;1.614
41Phentolamine1.614
42pirenperone1.614
43Promazine1.614
44Promethazine1.614
45Salmeterol Xinafoate1.614
46Thioridazine1.614
47Toxaphene1.614
48triflupromazine hydrochloride1.614
49Oleic Acid1.393
50Quetiapine Fumarate1.393

Showing top 50 of 145 compounds. Use the BiohacksAI search to explore all KCNH2 modulators.

About KCNH2 as a Drug Target

KCNH2 (potassium voltage-gated channel subfamily H member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 145 compounds with documented KCNH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KCNH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.